NCT01496638Active, not recruiting
The Nordic-Baltic Bifurcation Study IV
How Should Coronary Artery Stenoses With Significant Side Branch be Stented? A Strategy of Stenting Both Main Vessel and Side Branch Compared to a Strategy of Stenting the Main Vessel and Only Stenting the Side Branch if Necessary.
Source: ClinicalTrials.gov · Last updated 2 Jan 2026
Brief summary (registry, in English)
How should coronary artery stenoses with significant side branch be stented? A strategy of stenting both main vessel and side branch compared to a strategy of stenting the main vessel and only stenting the side branch if necessary. The 2-stent strategy is superior to the 1-stent strategy regarding occurrence of cardiac death, non-procedure related myocardial infarction and re-revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 450 (actual)
- First submitted
- 19 Dec 2011
- Start date
- Dec 2008
- Primary completion date
- Dec 2012
- Lead sponsor
- Evald Hoej Christiansen
- Diseases
- Coronary artery disease
- NCT number
- NCT01496638
What you commit to
- Study type: Interventional
- Participants enrolled: 450
- From Dec 2008 to the primary completion date, Dec 2012
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Allergy to Aspirin, Clopidogrel or Ticlopidine.
- Allergy to Sirolimus.
Lab values
- S-creatinine \>200 µmol/l.
Other
- ST-elevation infarction within 24 hours.
- Side branch lesion length \>15 mm.
- Expected survival \< 1 year.
Who the study is looking for
- Stable or unstable angina pectoris or silent angina pectoris.
- Genuine bifurcation lesion ( Medina type 1,1,1 or 1,0,1 or 0,1,1)
- Lesion of "LAD/diagonal", "Cx/obtuse marginal", "RCA-PDA/posterolateral branch" or "LM/Cx/LAD".
- Diameter of main vessel by visual estimate \>3.0 mm.
- Diameter of side branch by visual estimate \>2.75 mm.
- Signed informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aarhus University Hospital Coordinator of this site? Confirm its status | Skejby | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.